The LH surge induces the terminal differentiation and onset of luteinization in granulosa cells of preovulatory follicles, a process that involves the differential expression of genes essential for steroidogenesis and appears to be mediated by complex signaling pathways. The objective of this study was to investigate whether these processes that commonly occur in mural granulosa cells (MGCs) also occur in cumulus cells, and whether they are mediated by the mitogen-activated protein kinase (MAPK), specifically MAPK3/1 (also commonly known as extracellular signal-regulated kinase 1&2, ERK1/2). The standard superovulation model for premature female mice was used to obtain MGCs and cumulus-oocyte complexes (COCs), and sensitive real-time RT-PCR was used to simultaneously detect the expression levels of transcripts encoding key steroidogenic enzymes in the same sample. We observed significant downregulation of Cyp19a1 and upregulation of Star and Cyp11a1 mRNA expression in both COCs and MGCs after in vivo administration of hCG or in vitro treatment with gonadotropins or 8-Br-cAMP. This differential pattern of steroidogenic gene expression was correlated with the ultimate changes of circulating estradiol (E 2 ) and progesterone (P 4 ) levels after administration of hCG. In vitro, when MGCs and COCs were treated with U0126-a specific inhibitor of MAPK3/1 activation-gonadotropin-induced P 4 production, 8-Br-cAMP-induced P 4 production, and expression of Star and Cyp11a1 mRNA were significantly downregulated, whereas the levels of E 2 and Cyp19a1 mRNA in the same samples were significantly upregulated. We conclude that the surge of preovulatory LH induces the differential expression of transcripts encoding key steroidogenic enzymes essential for E 2 and P 4 synthesis in both cumulus and MGCs, and this process is mediated by the MAPK3/1-dependent pathway.
INTRODUCTION
In preovulatory follicles, granulosa cells enter a dramatic remodeling process, terminal differentiation, after the LH surge, which results in the onset of luteinization. This process appears to be mediated by complex intracellular signaling pathways that induce divergent changes in granulosa cells, including the distinct patterns of steroidogenic gene expression and steroidogenesis [1] . Specifically, the expression of Cyp19a1 encoding aromatase is rapidly inhibited [2] [3] [4] , whereas the expressions of Cyp11a1 and Star (encoding cholesterol side-chain cleavage cytochrome P450 and steroidogenic acute regulatory protein, respectively) are induced [3] [4] [5] [6] [7] . Accordingly, this change of gene expression in steroidogenic enzymes leads to the shift of steroidogenesis in granulosa cells from 17b-estradiol (E 2 ) to progesterone (P 4 ) [8, 9] . This transition of steriodigenesis is a hallmark of granulosa cell terminal differentiation and is essential for ovulation and luteinization.
The dynamic changes in steroidogenesis and steroidogenic gene expression in preovulatory follicles after the LH surge have been studied primarily in mural granulosa cells (MGCs), the subpopulation of granulosa cells that line the follicular wall. Whether similar changes also occur in cumulus cells, the subpopulation of granulosa cells surrounding the oocyte, is largely unknown. Although cumulus cells produce steroid hormones, their steroidogenic ability differs largely from MGCs [10] [11] [12] [13] , due to their direct proximity to the oocyte and interaction with oocyte-derived paracrine factors [12] [13] [14] [15] [16] . Cumulus cells express lower levels of CYP11A1 and CYP19A1 than MGCs and, hence, are less active in steroidogenesis [17, 18] . When cultured in the form of cumulus-oocyte complexes (COCs), they produce predominantly E 2 but not P 4 [12] [13] [14] [15] [16] . However, cumulus cells in ovulated COCs express high levels of CYP11A1 and actively synthesize P 4 [15, 19, 20] , implicating a dramatic change in their steroidogenic characteristics during the ovulatory process.
Given that E 2 and P 4 produced by cumulus cells may contribute to the control of the local steroidogenic environment of the oocyte to promote oocyte maturation and fertilization [21] [22] [23] [24] [25] [26] [27] , herein we investigated the dynamic changes in the expression of Star, Cyp11a1, and Cyp19a1 transcripts in COCs both in vivo and in vitro, compared with MGCs.
The mitogen-activated protein kinase 3 and 1 (MAPK3/1, also commonly known as extracellular signal-regulated kinase 1&2 [ERK1/2])-dependent pathway has been found to be involved in several key processes induced by the LH surge in preovulatory follicles. These processes include oocyte meiotic resumption [28] [29] [30] [31] [32] , cumulus expansion [29, 33] , gene expression [30, 34, 35] , and the disruption of gap junctional communications within the follicle [28, 31] . This indicates that the MAPK3/1-dependent pathway participates in the induction of the ovulatory process. The MAPK3/1-dependent pathway also has been reported as being involved in the regulation of steroidogenesis in granulosa cells; however, its precise role in this process is controversial. Some studies suggest that activation of MAPK is required for promoting steroidogenesis and steroidogenic gene expression in granulosa cells [36] [37] [38] [39] [40] [41] [42] , whereas other studies indicate that activation of MAPK3/1 suppresses granulosa cell steroidogenesis and steroidogenic gene expression [38, [43] [44] [45] . Notably, most of the previous studies use either human luteinizing granulosa cells derived from patients receiving in vitro fertilization treatment or rat granulosa cells isolated from early antral follicles. Therefore, species-specific variations, as well as some other factors, such as the stage of granulosa cell development, may account for these discrepancies. Because the regulation of steroidogenesis and steroidogenic gene expression is a complex process [46, 47] , it is necessary to reevaluate the role of MAPK3/1 in the regulation of steriodogenesis in granulosa cells, especially in cumulus cells, using the standard culture system for mouse MGCs and COCs. Given that both the ovulation and the changes in granulosa cell steroidogenesis are major processes induced by the LH surge in preovulatory follicles and the MAPK3/1 pathway mediates several key events during ovulation, we hypothesized that the MAPK3/1-dependent pathway also participates in LH-induced differential regulation of steroidogenesis and steroidogenic gene expression in granulosa cells. We tested this hypothesis using well-established models for the culture of mouse MGCs and COCs isolated from preovulatory follicles of eCG-primed immature mice.
MATERIALS AND METHODS

Mice
Immature 22-to 24-day-old C57BL/63129 (B6/129) female mice were used for most of the experiments, except in the experiment determining steroid hormone levels, for which (C57BL/6J)3SJL F1 (B6SJL F1) mice were used. B6/129 mice were housed and bred at Stanford University Research Animal Facility. B6SJL F1 mice were obtained from The Jackson Laboratory. All animal protocols were approved by the Administrative Panel on Laboratory Animal Care at Stanford University, and all experiments were conducted in accordance with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals.
Isolation of MGCs and COCs
MGCs and COCs were isolated as described previously [48, 49] . Briefly, MGCs and COCs were released into the culture medium by puncturing the large antral follicles with a pair of 27-gauge needles connected to 1-ml syringes. COCs were aspirated using a mouth-controlled, small-bore glass pipette. After removal of COCs, small pieces of MGC clumps were collected and isolated by centrifugation at 1000 rpm for 5 min. Medium used for cell collection and culture was DMEM/F-12 (Invitrogen Corp., Grand Island, NY) supplemented with 500 nM androstenedione, 2 mM L-glutamine, 25 nM sodium selenite, 5 lg/ml transferrin, 3 mg/ml BSA, 75 mg/l penicillin G, and 50 mg/l streptomycin sulfate. All medium supplements were purchased from Sigma (St. Louis, MO).
Collection of MGCs and COCs after hCG Treatment In Vivo
Mice were initially primed with eCG (National Hormone and Peptide Program, NIDDK, Torrance, CA) for 44-46 h by i.p. injection (5 IU per mouse), then injected with hCG (5 IU per mouse; National Hormone and Peptide Program, NIDDK, Torrance, CA) for various times. Samples of COCs and MGCs at the timepoints of 0, 2, 4, and 8 h after hCG injection were collected by puncturing large antral follicles, whereas COCs at 24 h after hCG injection were collected from the oviduct by gently teasing apart the ampulla and releasing the COC mass into the collection medium. Both COCs and MGCs were finally resuspended in RLT buffer (Qiagen Inc, Valencia, CA) containing 1% of b-mercaptaethanol (Sigma, St. Louis, MO) for RNA isolation. Blood samples were collected accordingly at each timepoint after hCG treatment and clotted at room temperature for about 1.5 h. Sera were isolated by centrifuging the clotted blood at 4600 rpm for 15 min.
In Vitro Culture and Treatment of MGCs and COCs
Both MGCs and COCs were isolated from eCG-primed 22-day-old mice and were cultured in four-well multi dishes (Nunc, Copenhagen, Denmark) at the density of 1 3 10 5 MGCs or 60 COCs per 250 ll per well. The following treatments were conducted: 1) To study the kinetics of steroidogenic gene expression in vitro, MGCs and COCs were treated with 100 ng/ml LH or 1 mM 8-Br-cAMP for 4, 8, 24 , and 48 h. For each timepoint after culture, cells were collected in RLT buffer containing 1% of b-mercaptaethanol for RNA isolation and quantification of levels of transcripts encoding key steroidogenic enzymes. 2) To investigate the effect of inhibition of MAPK activity on steroidogenesis and steroidogenic gene expression in MGCs and COCs, MGCs and COCs were initially treated with 10 lM U0126 or an equal volume of dimethyl sulfoxide (DMSO; vehicle) for 30 min, then treated with 100 ng/ml LH, 100 ng/ml FSH, or 1 mM 8-Br-cAMP, respectively, and cultured for 48 h. At the end of culture, conditioned media were removed and collected for E 2 and P 4 assays (see below), and cells were collected for RNA isolation and quantification of levels of transcripts encoding key steroidogenic enzymes. 3) To test the early response of MGCs and COCs to the inhibition of MAPK activity, MGCs and COCs were initially treated with 10 lM U0126 or an equal volume of DMSO (vehicle) for 30 min, then treated with 100 ng/ml LH or 1 mM 8-Br-cAMP and cultured for only 4 h. At the end of culture, cells were collected for RNA isolation and quantification of levels of transcripts encoding key steroidogenic enzymes.
Analysis of Steroid Hormones
The levels of E 2 and P 4 in mouse serum were measured using the thirdgeneration Estradiol DA RIA kit and the Progesterone EIA kit, respectively, which were obtained from Diagnostic Systems Laboratories, Inc. (Webster, TX). All serum samples were diluted 7.5-fold (for E 2 ) and 5-fold (for P 4 ) prior to analysis, and the levels are presented as the actual concentration (pg/ml and ng/ml for E 2 and P 4 , respectively). The levels of E 2 and P 4 in the culture medium were measured using enzyme immunoassay kits obtained from Diagnostic Systems Laboratories, Inc., and are presented as the ratio of the ligand-and/or U0126-treated group to the control group (with only DMSO treatment).
Analysis of Steady-State mRNA Levels of Steroidogenic Genes
Isolation and purification of total RNA were accomplished using RNeasy Micro Kits (Qiagen). In vitro transcription was carried out at 378C for 1 h using the Omniscript RT Kit (Qiagen), in combination with oligo-dT and random hexamer primers purchased from Invitrogen Corp. (Grand Island, NY). Realtime PCR was then conducted to quantify the steady-state mRNA levels of Star, Cyp11a1, and Cyp19a1 using QuantiTect SYBR Green PCR Kits (Qiagen) on the Mx4000 Multiplex Quantitative PCR system (Stratagene, La Jolla, CA). To avoid potential contamination of genomic DNA in the RNA samples, one RNase-free DNase digestion step was incorporated in the RNA isolation process, and primers were designed to amplify a specific fragment spanning two exons. A dissociation curve analysis was performed at the end of the amplification process in order to evaluate the specificity of the PCR products. The same PCR products also were evaluated by agarose gel electrophoresis to confirm that only one unique PCR product was amplified for each gene of interest. Primers used in real-time PCR are shown in Table 1 . To determine the efficiency of each gene-specific PCR, standard curves were generated from realtime PCR using a dilution series of cDNA derived from MGCs isolated from large antral follicles after priming with eCG for 44-46 h. Similar PCR efficiencies were observed among the four pairs of primers (97.4%-103.2%). The threshold cycle (Ct) was used to determine relative expression levels, with 860 the housekeeping gene Rpl19 used as the internal control. The expression levels of transcripts are presented as the ratio of treated groups to controls.
Statistical Analysis
All experiments were repeated independently at least three times. Data are presented as mean 6 SEM. Statistical analysis was conducted using StatView software (SAS Institute, Inc., Cary, NC). Data were first compared by ANOVA, followed by Fisher protected least significant difference post hoc test. P , 0.05 was considered significantly different.
RESULTS
Differential Synthesis of E 2 and P 4 In Vivo after Administration of hCG
As indicated in Figure 1A , there was a pattern of biphasic E 2 production in mouse serum after administration of hCG in vivo. A transient increase in the levels of E 2 was detected at 2 h after hCG injection. After the peak at 2 h, the level of E 2 decreased over time. At 8 h after hCG administration, the level of E 2 in serum was almost undetectable. In contrast to the sharp decrease of serum E 2 level at 4-8 h after hCG injection, the levels of P 4 at the same timepoints were still significantly higher than the basal level (0 h of hCG injection) after the initial increase at 2 h after hCG injection (Fig. 1B) . Despite the initial significant increase in E 2 level at 2 h, the ratio of E 2 :P 4 gradually declined over time.
Differential Expression of Transcripts Encoding Key Steroidogenic Enzymes in MGCs and COCs In Vivo after hCG Administration
A time-dependent elevation of steady-state levels of Star and Cyp11a1 mRNA was observed in both MGCs ( Fig. 2A) and COCs (Fig. 2C ) in vivo after receiving hCG treatment. A significant increase in Star mRNA levels was noted at 4 h after hCG administration in MGCs and COCs, whereas that of Cyp11a1 mRNA began at 8 h after hCG injection. In contrast to the gradual increases of Star and Cyp11a1 mRNA levels, the levels of Cyp19a1 were only transiently elevated in both MGCs and COCs, followed by a rapid decline (Fig. 2, B and  D) . In both types of cells, the level of Cyp19a1 increased at 2-4 h after hCG injection and dramatically decreased thereafter.
Changes in steroidogenic gene expression were more dramatic in COCs than in MGCs. Before administration of hCG, expression of Star and Cyp11al mRNAs in COCs was extremely low. The levels of these two transcripts in MGCs were 57.3-and 111.1-fold higher than in COCs (Fig. 2E ). After treatment with hCG, the differences between MGCs and COCs in the expression of both transcripts were gradually minimized. By 8 h after hCG injection, the differences were diminished to 2.4-and 3.8-fold, respectively. In contrast to the striking differences in the expression of Star and Cyp11al at the time of hCG treatment, the levels of Cyp19a1 mRNA in MGCs were moderately higher (7.2-fold) than in COCs (Fig. 2F) . At 4 h after hCG administration, the difference between COCs and 
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MGCs in Cyp19a1 mRNA levels decreased to 4.9-fold, whereas at 8 h it increased to 13-fold, indicating that a more marked change of Cyp19a1 expression occurs in COCs compared with MGCs at these timepoints.
Kinetics of the Expression of Transcripts Encoding Key Steroidogenic Enzymes In Vitro in MGCs and COCs
A time-dependent induction of Star and Cyp11a1 mRNA levels by LH was observed in MGCs in vitro (Fig. 3A) . A significant increase in the level of Star mRNA was detected at 4 h after LH treatment, and the highest level was detected at 48 h. Significant induction of Cyp11a1 mRNA was observed at 24-48 h after LH treatment, with slower kinetics compared with Star. In contrast to the elevation of Star and Cyp11a1 mRNA levels, a significant decrease in the levels of Cyp19a1 mRNA was observed in MGCs at all timepoints after LH treatment, with the lowest level detected at 48 h (Fig. 3B) .
As few if any LH receptors are expressed in COCs, COCs do not respond to LH treatment. However, they do respond to membrane-permeable cAMP analogs or FSH treatment, and, hence, these reagents are commonly used in studies involving COCs [48, 50, 51] . Therefore, in the following studies, FSH and the cAMP analog, 8-Br-cAMP, were used to treat COCs. As shown in Figure 3C , the expression of Star mRNA was time dependently promoted by 8-Br-cAMP. Significant upregulation of Star mRNA was detected at 4 h, with a marked increase at 48 h. The kinetics for the elevation of Cyp11a1 mRNA were relatively slower, with a significant increase observed at 24-48 h after 8-Br-cAMP treatment. Interestingly, the magnitude of the elevation of mRNA levels for both genes in COCs (Fig.  3C ) was significantly greater than that in MGCs (Fig. 3A) . In contrast to the gradual increase in Star and Cyp11a1 mRNA expression in both MGCs and COCs, a biphasic regulation of Cyp19a1 mRNA expression by 8-Br-cAMP was observed in COCs in vitro (Fig. 3D) . A transient increase in Cyp19a1 mRNA was observed between 4 h and 8 h after 8-Br-cAMP treatment, followed by a rapid decrease at 24-48 h. At 24 h and 48 h after 8-Br-cAMP treatment, the level of Cyp19a1 mRNA in COCs declined to barely detectable levels.
Differential Role of MAPK in Regulating Steroidogenesis in MGCs and COCs
To investigate whether the MAPK-dependent pathway participates in regulation of granulosa cell steroidogenesis, the effect of a specific inhibitor of MAPK activation, U0126, on the synthesis of E 2 and P 4 was studied in cultured MGCs and COCs. In MGCs (Fig. 4A) , U0126 significantly inhibited both basal and LH-induced or 8-Br-cAMP-induced P 4 production. U0126 also significantly inhibited basal, FSHinduced and 8-Br-cAMP-induced P 4 production in cultured COCs (Fig. 4C) .
In contrast to the inhibition of P 4 synthesis, U0126 significantly enhanced the synthesis of E 2 in both control and LH-treated or 8-Br-cAMP-treated MGCs (Fig. 4B) . U0126 also significantly promoted the production of E 2 in control, 8-BrcAMP-treated, and FSH-treated COCs (Fig. 4D) .
Effect of MAPK Inhibitor on the Expression of Transcripts Encoding Key Steroidogenic Enzymes in MGCs and COCs
As differential expression of the three steroidogenic genes studied in granulosa cells was greatly pronounced at 48 h of in vitro culture, and differential regulation of E 2 and P 4 synthesis by a MAPK-dependent pathway also was observed at this timepoint, the question arises as to whether or not the MAPKdependent pathway also simultaneously participates in the differential regulation of steroidogenic gene expression. To test this possibility, we first investigated the effect of U0126 on the expression of Star, Cyp11a1, and Cyp19a1 mRNA in MGCs and COCs at 48 h of in vitro culture. As shown in Figure 5 , A and B, U0126 dramatically inhibited LH-induced and 8-BrcAMP-induced elevation of Star and Cyp11a1 mRNA levels in MGCs. Similarly, U0126 also significantly attenuated FSHinduced and 8-Br-cAMP-induced Star and Cyp11a1 mRNA expression in COCs (Fig. 5, D and E) . In both cultured MGCs and COCs, U0126 significantly decreased basal levels of Star and Cyp11a1 mRNA. In contrast to the inhibition of Star and Cyp11a1 mRNA levels, U0126 treatment dramatically elevated the expression of Cyp19a1 mRNA in both MGCs and COCs (Fig. 5, C and F) . As shown in Figure 5C , U0126 blocked LHinduced and 8-Br-cAMP-induced reduction of Cyp19a1 mRNA levels in MGCs, and the levels of Cyp19a1 mRNA in U0126-treated groups were even higher than the control groups without any treatment. Similarly, in COCs U0126 also blocked FSH-induced and 8-Br-cAMP-induced reduction of Cyp19a1 mRNA levels (Fig. 5F ). In both MGCs and COCs, U0126 also increased basal levels of Cyp19a1 mRNA in controls.
Because the earliest changes of steroidogenic gene expression in granulosa cells occurred at 4 h both in vivo and in vitro, it is of interest to know whether this early response of granulosa cells also is dependent on the activation of MAPK. To this end, we studied the effect of U0126 on LH-or cAMPinduced expression of Star and Cyp19a1 in granulosa cells cultured for 4 h. As the expression of Cyp11a1 did not change at this timepoint, we did not examine its expression in response to U0126 treatment. As shown in Figure 6 , A and C, LH and 8-Br-cAMP significantly elevated the expression of Star in MGCs and COCs. This stimulatory effect of LH and cAMP was markedly attenuated by U0126. Interestingly, in COCs, 8-Br-cAMP promoted the expression of Cyp19a1, and treatment of U0126 significantly augmented this stimulatory effect (Fig.  6D ). LH and U0126 did not significantly affect the expression of Cyp19a1 in MGCs after 4 h of treatment (Fig. 6C) .
DISCUSSION
Data presented here using the mouse model confirmed previous findings in rat [2] [3] [4] [5] [6] [7] and other mammalian species [52] [53] [54] [55] [56] showing that the LH surge induces the downregulation of Cyp19a1 and the upregulation of Cyp11a1 and Star in MGCs. More importantly, the data indicated similar changes in the expression of Cyp19a1, Cyp11a1, and Star transcripts in COCs after the LH surge, despite the many known characteristic differences between cumulus cells and MGCs. The differential expression of Cyp19a1, Cyp11a1, and Star transcripts in both MGCs and COCs correlated with the ultimate changes in levels of E 2 and P 4 in circulation.
The immediate changes in levels of E 2 and P 4 in serum after hCG administration preceded the changes in levels of Cyp19a1, Star, and Cyp11a1 transcripts in both MGCs and COCs, suggesting the initial changes of steroids in circulation are not dependent on the change of these transcripts in granulosa cells. This early change in E 2 and P 4 levels is probably caused by the immediate inhibition of CYP17A1 and augmentation of CYP11A1 activity, respectively, in theca cells by the LH surge, as reported previously [56] [57] [58] [59] . Nevertheless, our data indicate that the differential expression of Cyp19a1, Cyp11a1, and Star transcripts in both MGCs and COCs correlates well with the subsequent changes in The dramatic upregulation of Cyp11a1 and Star transcripts in COCs indicates that cumulus cells acquire vigorous P 4 -producing capacity after the LH surge. The similar observation has been reported recently by Richards' group [34, 51] . This suggests that, in addition to the well-known phenomenon of cumulus expansion, cumulus cells also undergo another remarkable remodeling process after the LH surge, becoming more prone to producing P 4 . Indeed, cumulus cells of ovulated COCs have been found to produce high levels of P 4 [15, 20, 60] . Because cumulus cells do not luteinize, P 4 produced by cumulus cells must play a unique role that differs from MGCs. A recent study by Jamnongjit et al. [61] suggests that P 4 produced by cumulus cells and MGCs may function as a paracrine factor to mediate LH-induced oocyte meiotic resumption in the mouse. However, given that mouse oocyte meiotic resumption normally starts at 2-4 h after the LH surge, which, as demonstrated here, precedes the apparent upregulation of Cyp11a1 and Star transcripts in COCs and MGCs, it is unlikely that P 4 produced by cumulus cells and MGCs plays such a physiologic role. Nevertheless, P 4 produced by cumulus cells may promote oocyte cytoplasmic maturation and fertilization [21] [22] [23] [24] [25] [26] [27] . It may also function as an autocrine factor to regulate the function of cumulus cells during the periovulatory period [51] .
We and others have previously demonstrated the activation of MAPK3/1 in MGCs and cumulus cells after administration of hCG in vivo or treatment with gonadotropins and cAMP analogs in vitro [28-31, 62, 63] . Activation of MAPK3/1 in both MGCs and cumulus cells, as well as oocyte meiotic resumption and cumulus expansion induced by gonadotropins or 8-Br-cAMP, was effectively blocked by 10 lM U0126, a specific inhibitor of MAPK3/1 activation [28-31, 62, 63] . These observations indicate that the MAPK3/1-dependent pathway in granulosa cells, presumably in cumulus cells, mediates the LH-induced early processes during ovulation (i.e., maturation of COCs). Here, using the same culture system of COCs and MGCs, we demonstrated that the same dose of U0126 (10 lM) inhibited gonadotropin-induced or 8-BrcAMP-induced differential synthesis of E 2 and P 4 , as well as differential expression of Cyp19a1, Cyp11a1, and Star. This suggests that the MAPK3/1-dependent pathway also participates in the LH-induced late process during ovulation (i.e., the terminal differentiation of granulosa cells). Therefore, further evidence is provided in support of the role of MAPK3/1-dependent pathway in propagating LH signaling in the preovulatory follicle. Although here we only addressed the MAPK3/1-dependent pathway, some other pathways, such as protein kinase A and MAPK14 (also commonly known as p38MAPK) pathways, may also participate in this process. As suggested by a recent study in Richards' group [51] , all three pathways may be involved in regulating the function of COCs during the ovulatory process, and potential crosstalk may exist. Thus, further studies are necessary to unveil other potential pathways involving in this process and its interactions with the MAPK3/1 pathway. Cyp19a1 expression [38] . Similar observations were made in a study using short-term cultured human granulosa-luteal cells, where inhibition of MAPK3/1 activation blocked cAMP-and PGE2-induced P 4 production [36] . However, contradictory results were shown in studies using immortalized granulosa cell lines and long-term cultured human luteinized granulosa cells, where inhibition of MAPK3/1 activity potentiated gonadotrophin-induced elevation of Star mRNA and P 4 levels [43, 44] . Because different species (i.e., rodents vs. humans), as well as different culture systems (i.e., primary short-term vs. cell line or long-term culture), were used in different studies, interpretation of these discrepancies needs to be made cautiously.
Because few, if any, LH receptors are expressed in COCs, changes in COCs during the ovulatory process are likely not induced directly by LH. Studies by Conti's group and others indicated that the epidermal growth factor (EGF)-like factors (i.e., amphiregulin, epiregulin, and betacellulin) are probably the paracrine factors that propagate LH signaling to COCs [64, 65] . Most intriguingly, a very recent study by Richards' group [51] demonstrated that these EGF-like factors induce the expression of Star and Cyp11a1 and the activation of MAPK3/ 1 in mouse COCs. These studies suggest that EGF-like factors are probably the intermediary mediators of the LH-induced MAPK3/1 activation, as well as the subsequent key processes in COCs (i.e., oocyte meiotic resumption, cumulus expansion, and terminal differentiation [acquisition of high steroidogenic activity]).
In summary, cumulus cells undergo remarkable changes in their steroidogenic capabilities after the LH surge, as demonstrated by the dramatic upregulation of Star and Cyp11a1 and the simultaneous downregulation of Cyp19a1 transcripts. These changes are comparable to those in MGCs. This differential expression of Cyp19a1, Star, and Cyp11a1 transcripts in both cumulus cells and MGCs is correlated with ultimate changes in circulating E 2 and P 4 levels and is mediated by the MAPK3/1-dependent pathway.
